Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Recruiting	Phase 2	2026-08-11		NCT06904183

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Guangdong Medical University	27
Anqing Municipal Hospital	8
First People's Hospital of Foshan	44
Guangzhou Development District Hospital	2
Huizhou Municipal Central Hospital	21
Jieyang People's Hospital	14
Jinan University Affiliated Shunde Hospital	1
Second Affiliated Hospital of Guangzhou Medical University	70
Zhongshan People's Hospital, Guangdong, China	46

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The second Affiliated Hospital of Guangzhou Medical University	Guangzhou	China	26